Stay updated on Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied with update dates (2026-02-05, 2026-02-03, 2026-02). A funding-lapse notice was removed from the page.
    Difference
    0.6%
    Check dated 2026-02-11T12:08:09.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a general notice about government funding lapse and NIH Clinical Center status, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:46:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI and metadata updates including a new glossary toggle and revised QC-related labels and revision/version notes; these changes do not affect core trial data, eligibility criteria, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:44:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown instead of v3.3.3; no changes to the study details or page behavior were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:43:43.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Florida, Maryland, and New York sites. Removed the prior state-specific location subsections; page revision updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T17:25:09.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the ClinicalTrials.gov page. No substantive changes to the study details are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:27:48.000Z thumbnail image

Stay in the know with updates to Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page.